Affiliation:
1. Central Hospital of Defense. General and Digestive Unit
2. Central Hospital of Defense, Spanish Ministry of Defense
3. Central Hospital of Defense. Unit of Surgical Research. Spanish Ministry of Defense, Spain.
4. University of Alcalá de Henares
Abstract
Abstract
Background and objective: There are many surgical maneuvers (Packing, Pringle maneuver, etc.), hemostatics with many forms of application (Flowable, Powder, Patch, etc.), coagulation activity (active, mechanical, etc.), or chemical structure (fibrin, thrombin, Modified Absorbable Polymers (MAP)) to manage hepatic bleeding in trauma surgery. In addition, both can always work together at the same time; however, could a single medicine be effective as a unique hemostatic surgical technique? Which could be better?
Methods: Twenty swine were prospectively randomized to receive either active or passive hemostatics (Floseal TM or Perclot TM). We used a novel severe liver injury model that caused exsanguinating hemorrhage. The main outcome measure was total blood loss volume.
Results: The total volume of blood loss, from injury to minute 120, was significantly lower in the Flowable group (407.5 cc; IqR:195.0 cc to 805.0 cc) than in the novel modified absorbable polymer group (1,107.5 cc; IqR:822.5 cc to 1,544.5 cc) (Hodges-Lehmann median difference: -645.0 cc; 95% CI: -1,144.0 cc to -280.0 cc; p=0.0087). With the exception of 6 min measurements (p=0.1136), the volume of blood lost was significantly lower in the flowable group than in the MAP group from injury to minutes 3, 9, 12, and 120. The mean arterial pressure gradually recovered in the flowable group up to 24 h, whereas in the MAP group, the mean arterial pressure was always below the baseline values. Kaplan–Meier survival analysis indicated similar rates of death between study groups (Logrank test p=0.3395)
Conclusions: Both the flowable and the MAP hemostatic agents were able to effectively control surgical bleeding in this severe liver injury model, although the flowable gelatin-thrombin agent provided quick and better bleeding control
Publisher
Research Square Platform LLC
Reference32 articles.
1. Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database;Corral M;Clinicoecon Outcomes Res,2015
2. Perioperative management of the bleeding patient;Ghadimi K;Br J Anaesth.,2016
3. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients;Stokes ME;BMC Health Serv Res,2011
4. Financial and clinical outcomes associated with surgical bleeding complications;Shander A;Surgery,2007
5. Patterns of use of hemostatic agents in patients undergoing major surgery;Wright JD;J Surg Res.,2014